Terms: = Thyroid cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE
70 results:
1. Polyautoimmunity in Patients With Anticyclic Citrullinated Peptide Antibody-Positive and -Negative Rheumatoid Arthritis: a Nationwide Cohort Study From Denmark.
Kristensen S; Hagelskjær AM; Cordtz R; Bliddal S; Mortensen AS; Nielsen CH; Feldt-Rasmussen U; Lauridsen KB; Dreyer L
J Rheumatol; 2024 Apr; 51(4):350-359. PubMed ID: 38302173
[TBL] [Abstract] [Full Text] [Related]
2. An integrated model incorporating deep learning, hand-crafted radiomics and clinical and US features to diagnose central lymph node metastasis in patients with papillary thyroid cancer.
Gao Y; Wang W; Yang Y; Xu Z; Lin Y; Lang T; Lei S; Xiao Y; Yang W; Huang W; Li Y
BMC Cancer; 2024 Jan; 24(1):69. PubMed ID: 38216936
[TBL] [Abstract] [Full Text] [Related]
3. Mapping global new-onset, worsening, and resolution of diabetes following partial pancreatectomy: a systematic review and meta-analysis.
Wei J; Ou Y; Chen J; Yu Z; Wang Z; Wang K; Yang D; Gao Y; Liu Y; Liu J; Zheng X
Int J Surg; 2024 Mar; 110(3):1770-1780. PubMed ID: 38126341
[TBL] [Abstract] [Full Text] [Related]
4. Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma.
Mao J; Tang L; Fang L; Tian C; Zhu Z; Li Y
Sci Rep; 2023 Oct; 13(1):18492. PubMed ID: 37898675
[TBL] [Abstract] [Full Text] [Related]
5. thyroid V40 is a good predictor for subclinical hypothyroidism in patients with nasopharyngeal carcinoma after intensity modulated radiation therapy: a randomized clinical trial.
Xu Y; Peng H; Su G; Cheng Y; Guo Q; Guo L; Peng XE; Ke J
Radiat Oncol; 2023 Aug; 18(1):141. PubMed ID: 37626342
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
[TBL] [Abstract] [Full Text] [Related]
7. machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
Murakami M; Fujimori N; Nakata K; Nakamura M; Hashimoto S; Kurahara H; Nishihara K; Abe T; Hashigo S; Kugiyama N; Ozawa E; Okamoto K; Ishida Y; Okano K; Takaki R; Shimamatsu Y; Ito T; Miki M; Oza N; Yamaguchi D; Yamamoto H; Takedomi H; Kawabe K; Akashi T; Miyahara K; Ohuchida J; Ogura Y; Nakashima Y; Ueki T; Ishigami K; Umakoshi H; Ueda K; Oono T; Ogawa Y
J Gastroenterol; 2023 Jun; 58(6):586-597. PubMed ID: 37099152
[TBL] [Abstract] [Full Text] [Related]
8. Value of clinical features combined with multimodal ultrasound in predicting lymph node metastasis in cervical central area of papillary thyroid carcinoma.
Xue J; Li S; Qu N; Wang G; Chen H; Wu Z; Cao X
J Clin Ultrasound; 2023 Jun; 51(5):908-918. PubMed ID: 37058552
[TBL] [Abstract] [Full Text] [Related]
9. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
Hao W; Zhao J; Guo F; Gu P; Zhang J; Huang D; Ruan X; Zeng Y; Zheng X; Gao M
PeerJ; 2023; 11():e15025. PubMed ID: 36935920
[TBL] [Abstract] [Full Text] [Related]
10. [Retrospective analysis of BI-RADS 4 and 5 lesions additionally detected by breast MRI].
Jiang L; Gao JY; Xu ZJ; He SR; Hua B
Zhonghua Wai Ke Za Zhi; 2023 Feb; 61(2):100-106. PubMed ID: 36720618
[No Abstract] [Full Text] [Related]
11. A model based on clinical data and multi-modal ultrasound for predicting cervical lymph node metastasis in patients with thyroid papillary carcinoma.
Wang B; Cao Q; Cui XW; Dietrich CF; Yi AJ
Front Endocrinol (Lausanne); 2022; 13():1063998. PubMed ID: 36578956
[TBL] [Abstract] [Full Text] [Related]
12. Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis.
Wang Z; Gui Z; Wang Z; Huang J; He L; Dong W; Zhang D; Zhang T; Shao L; Shi J; Wu P; Ji X; Zhang H; Sun W
Clin Endocrinol (Oxf); 2023 Apr; 98(4):609-621. PubMed ID: 36263602
[TBL] [Abstract] [Full Text] [Related]
13. Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment.
Tran TV; Rubino C; Allodji R; Andruccioli M; Bardet S; Diallo I; Dottorini M; Garsi J; Hall P; Henry-Amar M; Lamart S; Le Thai F; Lönn S; Ricard M; Schvartz C; Schlumberger M; Journy N; de Vathaire F
Br J Cancer; 2022 Dec; 127(12):2118-2124. PubMed ID: 36224404
[TBL] [Abstract] [Full Text] [Related]
14. machine learning for identifying benign and malignant of thyroid tumors: A retrospective study of 2,423 patients.
Guo YY; Li ZJ; Du C; Gong J; Liao P; Zhang JX; Shao C
Front Public Health; 2022; 10():960740. PubMed ID: 36187616
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of visual evoked potentials in dysthyroid optic neuropathy.
Garip Kübler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Rudolph G; Hintschich C
Orbit; 2023 Oct; 42(5):475-480. PubMed ID: 36128945
[TBL] [Abstract] [Full Text] [Related]
16. Risk of Adverse Cardiovascular Outcomes in Differentiated thyroid cancer Survivors: A Systematic Review and Meta-Analysis.
Qiang JK; Alwithenani R; Uleryk E; Ezzat S; Lipscombe LL; Sawka AM
Thyroid; 2023 Feb; 33(2):192-202. PubMed ID: 36074932
[No Abstract] [Full Text] [Related]
17. Application of Artificial Intelligence Computer-Assisted Diagnosis Originally Developed for thyroid Nodules to Breast Lesions on Ultrasound.
Lee SE; Lee E; Kim EK; Yoon JH; Park VY; Youk JH; Kwak JY
J Digit Imaging; 2022 Dec; 35(6):1699-1707. PubMed ID: 35902445
[TBL] [Abstract] [Full Text] [Related]
18. RPS27 selectively regulates the expression and alternative splicing of inflammatory and immune response genes in thyroid cancer cells.
Wan J; Lv J; Wang C; Zhang L
Adv Clin Exp Med; 2022 Aug; 31(8):889-901. PubMed ID: 35546566
[TBL] [Abstract] [Full Text] [Related]
19. Radiomic Model for Determining the Value of Elasticity and Grayscale Ultrasound Diagnoses for Predicting BRAF
Wang YG; Xu FJ; Agyekum EA; Xiang H; Wang YD; Zhang J; Sun H; Zhang GL; Bo XS; Lv WZ; Wang X; Hu SD; Qian XQ
Front Endocrinol (Lausanne); 2022; 13():872153. PubMed ID: 35527993
[TBL] [Abstract] [Full Text] [Related]
20. Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis.
Cui M; Wang Z; Huang LT; Wang JH
BMC Complement Med Ther; 2022 Apr; 22(1):99. PubMed ID: 35366876
[TBL] [Abstract] [Full Text] [Related]
[Next]
